Teladoc Health (TDOC) Capital Expenditures (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Capital Expenditures data on file, last reported at $34.2 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 1153.19% year-over-year to $34.2 million; the trailing twelve-month figure through Mar 2026 stood at $150.0 million (up 30.62% YoY), and the FY2025 full-year result was $118.6 million, up 4.68% from the prior year.
• Capital Expenditures rose to $34.2 million in Q1 2026, from $31.7 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $146.0 million in Q4 2022 to a low of -$67.9 million in Q3 2023.
• A 5-year average of $25.5 million and a median of $29.0 million in 2025 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures slumped 1871.98% in 2023 and soared 7635.33% in 2024, its largest moves.
• Tracing TDOC's Capital Expenditures over 5 years: stood at $146.0 million in 2022, then slumped by 99.04% to $1.4 million in 2023, then soared by 7635.33% to $108.6 million in 2024, then plunged by 70.81% to $31.7 million in 2025, then increased by 7.77% to $34.2 million in 2026.
• Business Quant data shows TDOC's Capital Expenditures at $34.2 million in Q1 2026, $31.7 million in Q4 2025, and $29.0 million in Q3 2025.